Atlas Trials

A Pilot Study of the Effects of Mirabegron on Symptoms in Patients With Interstitial Cystitis

Clinical trial NCT02787083 · TERMINATED

Trial details

NCT number
NCT02787083
Sponsor
Philadelphia Urosurgical Associates
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Cystitis, Interstitial
Start date
2016-08-01
Primary completion
2019-07-05
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.